|Bid||180.27 x 1800|
|Ask||180.99 x 900|
|Day's range||181.68 - 181.95|
|52-week range||107.51 - 206.90|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||32.21|
|Forward dividend & yield||2.72 (1.46%)|
|Ex-dividend date||10 Aug 2020|
|1y target est||N/A|
The owner of the Corona beer franchise has more room to grow than its larger alcoholic-beverage peer.
Investors could hardly be more optimistic heading into Boston Beer's (NYSE: SAM) Oct. 22 earnings report. There's every reason to expect industry-leading sales growth trends for the period that ran from July through September. Boston Beer revealed a 46% spike in depletions (a measure of consumption) in the most recent quarter, which marked an acceleration over the prior quarter's boost.
P&G's latest earnings underscore the ongoing impact of the COVID-19 pandemic.